22 C
Vientiane
Wednesday, October 29, 2025
spot_img

Cision PR Newswire

A Breakthrough in Color Measurement Is Coming: The HunterLab Agera L2

RESTON, Va., Oct. 29, 2025 /PRNewswire/ -- A breakthrough in color measurement is on the horizon. This November, HunterLab will unveil the Agera L2, the next...

Asia-Pacific to strengthen cooperation and build an open world economy

BEIJING, Oct. 28, 2025 /PRNewswire/ -- A report from People's Daily: As the...

PTS to Launch Japan-Origin Bitcoin Mining Investment Product via Republic Platform Under U.S. Regulation

YOKOHAMA, Japan, Oct. 29, 2025 /PRNewswire/ -- Pivotal Trend Service (PTS), a Yokohama-based infrastructure...

SK hynix Announces 3Q25 Financial Results

-     Reports revenues of 24.4489 trillion won, operating profit of 11.3834 trillion won, net profit...

WEKA Announces New NeuralMesh Architecture Built for NVIDIA BlueField-4

Revolutionary Platform Design Marks Major Evolution in AI Infrastructure, Eliminating Traditional CPU Requirements While...

Dx&Vx Presents a New Paradigm for Next-Generation Infectious Disease Response with the Development of a Universal Vaccine

- Preparing for Phase 2 Global Trials of a Ferritin Platform-Based Virus-Like Particle Universal Coronavirus Vaccine - Based on the Excellent Safety and Immune Response in...

Trillium Flow Technologies Successfully Completes Refinancing

STAMFORD, Conn., Jan. 13, 2025 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve, and a global designer, manufacturer, and aftermarket...

ZEISS MEL 90 excimer laser receives U.S. FDA approval; completes Corneal Refractive Workflow

The excimer laser complements the ZEISS VISUMAX 800 with ZEISS SMILE pro, extending ZEISS' LVC market leadership with treatment for myopia, hyperopia, and mixed...

WXT Surged 101% in 24 hours, And the Price Exceeded $0.339.Why Can WXT Go to the Moon?

SINGAPORE, Jan. 13, 2025 /PRNewswire/ -- Platform tokens have gained increased attention in this bull market, with notable examples from leading exchanges. Amid this...

CARsgen’s Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in an Investigator-Initiated Trial

SHANGHAI, Jan. 13, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment...

Nature’s Miracle Holding, Inc. Announces Up to $29.7 Million Financing

ONTARIO, Calif., Jan. 13, 2025 /PRNewswire/ -- Nature's Miracle Holding, Inc. (Nasdaq: NMHI) ("Nature's Miracle"), a growing agriculture technology company providing equipment and services...